List of Enzon Pharmaceuticals patents | 6 results

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8367065 Targeted polymeric prodrugs containing multifunctional linkers	Patent 8367065 was granted and assigned to Enzon Pharmaceuticals on February, 2013 by the United States Patent and Trademark Office.	‌ Enzon Pharmaceuticals	United States Patent and Trademark Office	8367065	February 5, 2013
‌ US Patent 8168605 Polymeric oligonucleotide prodrugs	Patent 8168605 was granted and assigned to Enzon Pharmaceuticals on May, 2012 by the United States Patent and Trademark Office.	‌ Enzon Pharmaceuticals	United States Patent and Trademark Office	8168605	May 1, 2012
‌ US Patent 8133707 Methods of preparing activated polymers having alpha nitrogen groups	Patent 8133707 was granted and assigned to Enzon Pharmaceuticals on March, 2012 by the United States Patent and Trademark Office.	‌ Enzon Pharmaceuticals	United States Patent and Trademark Office	8133707	March 13, 2012
‌ US Patent 8192743 Releasable polymeric conjugates based on aliphatic biodegradable linkers	Patent 8192743 was granted and assigned to Enzon Pharmaceuticals on June, 2012 by the United States Patent and Trademark Office.	‌ Enzon Pharmaceuticals	United States Patent and Trademark Office	8192743	June 5, 2012
‌ US Patent 8268318 Polyalkylene oxides having hindered ester-based biodegradable linkers	Patent 8268318 was granted and assigned to Enzon Pharmaceuticals on September, 2012 by the United States Patent and Trademark Office.	‌ Enzon Pharmaceuticals	United States Patent and Trademark Office	8268318	September 18, 2012
‌ US Patent 8299089 Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers	Patent 8299089 was granted and assigned to Enzon Pharmaceuticals on October, 2012 by the United States Patent and Trademark Office.	‌ Enzon Pharmaceuticals	United States Patent and Trademark Office	8299089	October 30, 2012